首页 | 本学科首页   官方微博 | 高级检索  
     


CD24 is a genetic modifier for risk and progression of prostate cancer
Authors:Yifan Zhang  Bingjin Li  Xingyi Zhang  Guru P. Sonpavde  Kenneth Jiao  Andrea Zhang  Guangxin Zhang  Mei Sun  Chengjing Chu  Feng Li  Lizhong Wang  Ranji Cui  Runhua Liu
Affiliation:1. Departmentof Thoracic Surgery, The Second Hospital of Jilin University, Changchun, P.R. China;2. Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama;3. Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, Second Hospital of Jilin University, Changchun, P.R. China;4. Department of Internal Medicine, Section of Medical Oncology, University of Alabama at Birmingham, Birmingham, Alabama;5. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama;6. Department of Pathology, The Second Hospital of Jilin University, Changchun, P.R. China;7. Department of Health and Social Science, Guangdong Medical College, Dongguan, P.R. China;8. Anshan Normal University Affiliated Health School, Anshan, P.R. China
Abstract:
Keywords:CD24  polymorphism  prostate cancer  tumor progression
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号